Overall Fundamental outlook

Business Operations:

Sector: Basic Materials
Industry: Agricultural Inputs

UPL Limited, together with its subsidiaries, engages in the provision of sustainable agriculture products and solutions in India, Europe, North America, Latin America, and internationally. It operates through three segments: Crop Protection, Seeds Business, and Non-Agro. The Crop Protection segment provides herbicides, fungicides, insecticides, acaricides, seed treatment products, adjuvants, bio-solutions, public health products, fumigants, and post-harvest solutions, as well as ProNutiva, a solution for crop protection. The segment also operates nurture.farm, a Nurture AgTech platform, that provides booking options for farmers in accessing mechanized spraying, harvesting, farm advisory, and soil testing services digitally via a mobile application; and nurture.farm retail, a platform that serves as an agricultural input e-commerce marketplace. The Seeds Business segment offers various hybrid seeds of grain, forage sorghum, corn, canola, sunflower, and vegetables under Advanta, Alta, Pacific Seeds, and Empyr brands. The Non-Agro segment provides phosphorus derivatives, sulphur derivatives, bitterant, phosgene derivatives, chlorination, cyanation chemistry, phosphodiesterase inhibiting bronchodilator, and CNS stimulant products for pharma, agchem, paints, flame retardants, mining, chemical intermediate markets. It also offers Decco FullCover, an electrostatic application system that allows minimal fruit coating volumes; DeccoNaturCover, a formula, which features natural extracts to prevent fruit dehydration and preserve its natural appearance; DeccoArcAqua, a technology, that enables ozone release in water-based solutions; and Zeba, a solution n for soil and water management. The company was formerly known as United Phosphorus Limited and changed its name to UPL Limited in October 2013. UPL Limited was founded in 1969 and is headquartered in Mumbai, India.

Revenue projections:

Revenue projections for UPL
Revenue projections for UPL

UPL's revenue projections indicate a decrease from last year's performance, which could lead to investor caution. A fall in revenue is likely to negatively impact the company's profitability, causing concern for shareholders who may view this as a signal of declining financial health.

Financial Ratios:

currentRatio 0.000000
forwardPE 15.879205
debtToEquity 66.354000
earningsGrowth 0.000000
revenueGrowth 0.016000
grossMargins 0.489760
operatingMargins 0.062070
trailingEps 13.540000
forwardEps 47.960000

UPL's Forward PE is in a reasonable range, indicating the stock is priced well relative to its earnings. The stock isn't overpriced, which leaves room for future growth, making it an attractive option for investors seeking value and long-term gains.
With UPL's forward EPS higher than its trailing EPS, the company is expected to be more profitable in the current financial year. This signals confidence in UPL's growth potential, as improved earnings are forecasted compared to the prior year's performance.

Price projections:

Price projections for UPL
Price projections for UPL

Over time, price projections for UPL have risen steadily, pointing to growing optimism among analysts about the company's future. This upward trend suggests a positive outlook for UPL's continued growth.

Insider Transactions:

Insider Transactions for UPL
Insider Transactions for UPL


UPL had 4 sell transactions, while the market price was at 589.9250030517578 per share.There were no sell transactions throughout the period under consideration.The recent buying activity at current UPL price levels exceeds selling, suggesting a potential positive outlook. Investors may see this trend as an indicator that the stock is likely to perform well, reflecting growing confidence.

Recommendation changes over time:

Recommendations trend for UPL
Recommendations trend for UPL


Analysts have shown a buy bias for UPL, marking it as a favorable investment option. This could inspire investors to see UPL as a strong place to park their money, given the positive outlook and growth potential associated with the stock in recent evaluations.